Jyong Biotech targets urinary disorders with a novel botanical pipeline, but clinical and liquidity risks temper near-term ...

The global statistics are terrifying. Prostate cancer is the fourth most common cancer in all populations, the second most ...

In a significant advancement for prostate cancer research, a first-of-its-kind study led by Emory researchers uncovered how ...

Men on active surveillance for low- to intermediate-risk prostate cancer (PCa) have low risk for PCa-related mortality at a median follow-up of 18 years. However, a majority of men do progress and ...

With an estimated 1.5 million new cases and 397,000 deaths worldwide, prostate cancer is the world's second most frequent ...

Prostate cancer, a growing concern worldwide, often progresses silently, making early detection crucial. Symptoms like ...

Results of a study led by VHIO’s Prostate Cancer Group suggest that treatment with CDK4/6 inhibitors followed by senloytic ...

Cardiac biomarkers may not only be indicative of cardiac events, but could also be predictive of future cancer diagnosis, ...